In last trading session, Corcept Therapeutics Inc (NASDAQ:CORT) saw 1.98 million shares changing hands with its beta currently measuring 0.59. Company’s recent per share price level of $65.09 trading at -$8.44 or -11.48% at ring of the bell on the day assigns it a market valuation of $6.82B. That closing price of CORT’s stock is at a discount of -15.23% from its 52-week high price of $75.00 and is indicating a premium of 67.98% from its 52-week low price of $20.84.
For Corcept Therapeutics Inc (CORT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.42 in the current quarter.
Corcept Therapeutics Inc (NASDAQ:CORT) trade information
Upright in the red during last session for losing -11.48%, in the last five days CORT remained trading in the red while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $65.09 price level, adding 13.21% to its value on the day. Corcept Therapeutics Inc’s shares saw a change of 29.17% in year-to-date performance and have moved -7.21% in past 5-day. Corcept Therapeutics Inc (NASDAQ:CORT) showed a performance of 6.51% in past 30-days.
Wall Street analysts have assigned a consensus price target of 78 to the stock, which implies a rise of 16.55% to its current value. Analysts have been projecting 76 as a low price target for the stock while placing it at a high target of 80. It follows that stock’s current price would drop -16.76% in reaching the projected high whereas dropping to the targeted low would mean a loss of -16.76% for stock’s current value.
Corcept Therapeutics Inc (CORT) estimates and forecasts
This year revenue growth is estimated to rise 43.71% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 200.12M for the same. And 3 analysts are in estimates of company making revenue of 200.07M in the next quarter. Company posted 135.41M and 146.81M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 9.67% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 49.74% while estimates for its earnings growth in next 5 years are of 68.27%.
Corcept Therapeutics Inc (NASDAQ:CORT)’s Major holders
BLACKROCK INC. is the top institutional holder at CORT for having 16.54 million shares of worth $537.36 million. And as of 2024-06-30, it was holding 16.0901 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 9.55 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2943 of outstanding shares, having a total worth of $310.4 million.
